Advertisement
American Journal of Kidney Diseases

Ultrafiltration Rate Thresholds in Maintenance Hemodialysis: An NKF-KDOQI Controversies Report

      High hemodialysis ultrafiltration rate (UFR) is increasingly recognized as an important and modifiable risk factor for mortality among patients receiving maintenance hemodialysis. Recently, the Kidney Care Quality Alliance (KCQA) developed a UFR measure to assess dialysis unit care quality. The UFR measure was defined as UFR ≥ 13 mL/kg/h for patients with dialysis session length less than 240 minutes and was endorsed by the National Quality Forum as a quality measure in December 2015. Despite this, implementation of a UFR threshold remains controversial. In this NKF-KDOQI (National Kidney Foundation−Kidney Disease Outcomes Quality Initiative) Controversies Report, we discuss the concept of the UFR, which is governed by patients’ interdialytic weight gain, body weight, and dialysis treatment time. We also examine the potential benefits and pitfalls of adopting a UFR threshold as a clinical performance measure and outline several aspects of UFR thresholds that require further research.

      Index Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Kidney Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • National Kidney Foundation
        DOQI clinical practice guidelines for hemodialysis adequacy.
        Am J Kidney Dis. 1997; 30: S15-S66
        • Lowrie E.G.
        • Laird N.M.
        • Parker T.F.
        • Sargent J.A.
        Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study.
        N Engl J Med. 1981; 305: 1176-1181
        • Eknoyan G.
        • Beck G.J.
        • Cheung A.K.
        • et al.
        Effect of dialysis dose and membrane flux in maintenance hemodialysis.
        N Engl J Med. 2002; 347: 2010-2019
        • National Kidney Foundation
        KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update.
        Am J Kidney Dis. 2015; 66: 884-930
        • Agar J.W.
        Personal viewpoint: limiting maximum ultrafiltration rate as a potential new measure of dialysis adequacy [published online ahead of print March 16, 2015].
        Hemodialysis Int. 2016; 20: 15-21
        • Flythe J.E.
        • Xue H.
        • Lynch K.E.
        • Curhan G.C.
        • Brunelli S.M.
        Association of mortality risk with various definitions of intradialytic hypotension.
        J Am Soc Nephrol. 2015; 26: 724-734
        • NKF-KDOQI Hemodialysis Adequacy 2006 Work Group
        Clinical practice guidelines for hemodialysis adequacy, update 2006.
        Am J Kidney Dis. 2006; 48: S33
        • National Kidney Foundation
        I. K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000.
        Am J Kidney Dis. 2001; 37: S7-S64
        • Blagg C.R.
        The early history of dialysis for chronic renal failure in the United States: a view from Seattle.
        Am J Kidney Dis. 2007; 49: 482-496
        • De Palma J.R.
        • Bolton C.F.
        • Baltzan M.A.
        • Baltzan R.B.
        Adequate hemodialysis schedule.
        N Engl J Med. 1971; 285: 353-354
        • Gotch F.A.
        • Sargent J.A.
        A mechanistic analysis of the National Cooperative Dialysis Study (NCDS).
        Kidney Int. 1985; 28: 526-534
        • Capelli J.P.
        • Kushner H.
        • Camiscioli T.
        • Chen S.M.
        • Stuccio-White N.M.
        Factors affecting survival of hemodialysis patients utilizing urea kinetic modeling. A critical appraisal of shortening dialysis times.
        Am J Nephrol. 1992; 12: 212-223
        • European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association
        Section II. Haemodialysis adequacy.
        Nephrol Dial Transplant. 2002; 17: 16-31
      1. Arbor Research Collaborative for Health. Dialysis Outcomes and Practice Patterns Study annual report 2012. http://www.dopps.org/annualreport/html/qdialduration_US2011.htm. Accessed December 9, 2015.

        • Tentori F.
        • Zhang J.
        • Li Y.
        • et al.
        Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
        Nephrol Dial Transplant. 2012; 27: 4180-4188
        • Brunelli S.M.
        • Chertow G.M.
        • Ankers E.D.
        • Lowrie E.G.
        • Thadhani R.
        Shorter dialysis times are associated with higher mortality among incident hemodialysis patients.
        Kidney Int. 2010; 77: 630-636
        • Saran R.
        • Bragg-Gresham J.L.
        • Levin N.W.
        • et al.
        Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.
        Kidney Int. 2006; 69: 1222-1228
        • Flythe J.E.
        • Kimmel S.E.
        • Brunelli S.M.
        Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality.
        Kidney Int. 2011; 79: 250-257
        • Movilli E.
        • Gaggia P.
        • Zubani R.
        • et al.
        Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study.
        Nephrol Dial Transplant. 2007; 22: 3547-3552
        • McIntyre C.W.
        • Burton J.O.
        • Selby N.M.
        • et al.
        Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow.
        Clin J Am Soc Nephrol. 2008; 3: 19-26
        • Dasselaar J.J.
        • Slart R.H.
        • Knip M.
        • et al.
        Haemodialysis is associated with a pronounced fall in myocardial perfusion.
        Nephrol Dial Transplant. 2009; 24: 604-610
        • Bolli R.
        • Marban E.
        Molecular and cellular mechanisms of myocardial stunning.
        Physiol Rev. 1999; 79: 609-634
        • Burton J.O.
        • Jefferies H.J.
        • Selby N.M.
        • McIntyre C.W.
        Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function.
        Clin J Am Soc Nephrol. 2009; 4: 1925-1931
        • Burton J.O.
        • Korsheed S.
        • Grundy B.J.
        • McIntyre C.W.
        Hemodialysis-induced left ventricular dysfunction is associated with an increase in ventricular arrhythmias.
        Ren Fail. 2008; 30: 701-709
        • Narula A.S.
        • Jha V.
        • Bali H.K.
        • Sakhuja V.
        • Sapru R.P.
        Cardiac arrhythmias and silent myocardial ischemia during hemodialysis.
        Ren Fail. 2000; 22: 355-368
        • Mohi-ud-din K.
        • Bali H.K.
        • Banerjee S.
        • Sakhuja V.
        • Jha V.
        Silent myocardial ischemia and high-grade ventricular arrhythmias in patients on maintenance hemodialysis.
        Ren Fail. 2005; 27: 171-175
        • Assa S.
        • Hummel Y.M.
        • Voors A.A.
        • et al.
        Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance.
        Clin J Am Soc Nephrol. 2012; 7: 1615-1623
        • Selby N.M.
        • Burton J.O.
        • Chesterton L.J.
        • McIntyre C.W.
        Dialysis-induced regional left ventricular dysfunction is ameliorated by cooling the dialysate.
        Clin J Am Soc Nephrol. 2006; 1: 1216-1225
        • Jefferies H.J.
        • Virk B.
        • Schiller B.
        • Moran J.
        • McIntyre C.W.
        Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).
        Clin J Am Soc Nephrol. 2011; 6: 1326-1332
        • Selby N.M.
        • Lambie S.H.
        • Camici P.G.
        • Baker C.S.
        • McIntyre C.W.
        Occurrence of regional left ventricular dysfunction in patients undergoing standard and biofeedback dialysis.
        Am J Kidney Dis. 2006; 47: 830-841
      2. [No author given]. Arbor Research Collaborative for Health and University of Michigan Kidney Epidemiology and Cost Center. Clinical and Data Technical Expert Panel Meetings Synthesis Report. Bethesda, MD: Department of Health and Human Services, Centers for Medicare and Medicaid Services; 2010. https://www.cms.gov/Medicare/End-stage-renal-Disease/CPMProject/downloads/ESRD2010TechnicalExpertPanelReport.pdf. Accessed November 13, 2015.

        • Weiner D.E.
        • Brunelli S.M.
        • Hunt A.
        • et al.
        Improving clinical outcomes among hemodialysis patients: a proposal for a “volume first” approach from the chief medical officers of US dialysis providers.
        Am J Kidney Dis. 2014; 64: 685-695
      3. [No author given]. Kidney Care Partners. http://kidneycarepartners.com/about-kcp/. Accessed December 1, 2015.

      4. Zumoff R. National Quality Forum endorses ultrafiltration measure for dialysis patients. Nephrology News and Issues. December 8, 2015. http://www.nephrologynews.com/national-quality-forum-endorses-ultrafiltration-measure-for-dialysis-patients/. Accessed December 8, 2015.

      5. Mactier R, Hoenich N, Breen C. Renal Association guidelines-haemodialysis, 2009. http://www.renal.org/guidelines/modules/haemodialysis#s8. Accessed December 1, 2015.

        • Agarwal R.
        • Weir M.R.
        Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.
        Clin J Am Soc Nephrol. 2010; 5: 1255-1260
        • Kayikcioglu M.
        • Tumuklu M.
        • Ozkahya M.
        • et al.
        The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.
        Nephrol Dial Transplant. 2009; 24: 956-962
        • Munoz Mendoza J.
        • Arramreddy R.
        • Schiller B.
        Dialysate sodium: choosing the optimal hemodialysis bath.
        Am J Kidney Dis. 2015; 66: 710-720
        • Davenport A.
        • Cox C.
        • Thuraisingham R.
        • PanThames Renal Audit Group
        The importance of dialysate sodium concentration in determining interdialytic weight gains in chronic hemodialysis patients: the PanThames renal audit.
        Int J Artif Organs. 2008; 31: 411-417
        • Arramreddy R.
        • Sun S.J.
        • Munoz Mendoza J.
        • Chertow G.M.
        • Schiller B.
        Individualized reduction in dialysate sodium in conventional in-center hemodialysis.
        Hemodial Int. 2012; 16: 473-480
        • Song J.H.
        • Park G.H.
        • Lee S.Y.
        • Lee S.W.
        • Lee S.W.
        • Kim M.J.
        Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.
        J Am Soc Nephrol. 2005; 16: 237-246
        • Stiller S.
        • Bonnie-Schorn E.
        • Grassmann A.
        • Uhlenbusch-Korwer I.
        • Mann H.
        A critical review of sodium profiling for hemodialysis.
        Semin Dial. 2001; 14: 337-347
        • Sang G.L.
        • Kovithavongs C.
        • Ulan R.
        • Kjellstrand C.M.
        Sodium ramping in hemodialysis: a study of beneficial and adverse effects.
        Am J Kidney Dis. 1997; 29: 669-677
        • Zhou Y.L.
        • Liu H.L.
        • Duan X.F.
        • Yao Y.
        • Sun Y.
        • Liu Q.
        Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension.
        Nephrol Dial Transplant. 2006; 21: 3231-3237
        • de Vries P.M.
        • Olthof C.G.
        • Solf A.
        • et al.
        Fluid balance during haemodialysis and haemofiltration: the effect of dialysate sodium and a variable ultrafiltration rate.
        Nephrol Dial Transplant. 1991; 6: 257-263
        • Santos S.F.
        • Peixoto A.J.
        Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients.
        Clin J Am Soc Nephrol. 2008; 3: 522-530
        • de Paula F.M.
        • Peixoto A.J.
        • Pinto L.V.
        • Dorigo D.
        • Patricio P.J.
        • Santos S.F.
        Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients.
        Kidney Int. 2004; 66: 1232-1238
        • Gul A.
        • Miskulin D.C.
        • Paine S.S.
        • et al.
        Comparison of prescribed and measured dialysate sodium: a quality improvement project.
        Am J Kidney Dis. 2016; 67: 439-445
        • Flythe J.E.
        • Mangione T.W.
        • Brunelli S.M.
        • Curhan G.C.
        Patient-stated preferences regarding volume-related risk mitigation strategies for hemodialysis.
        Clin J Am Soc Nephrol. 2014; 9: 1418-1425
        • Jardine M.J.
        • Zuo L.I.
        • Gray N.A.
        • et al.
        Design and participant baseline characteristics of 'A clinical trial of IntensiVE dialysis': the ACTIVE dialysis study.
        Nephrology (Carlton). 2015; 20: 257-265
        • Thomson G.E.
        • Waterhouse K.
        • McDonald Jr., H.P.
        • Friedman E.A.
        Hemodialysis for chronic renal failure. Clinical observations.
        Arch Intern Med. 1967; 120: 153-167
        • Sinha A.D.
        • Agarwal R.
        Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status.
        Semin Dial. 2009; 22: 480-482
        • Agarwal R.
        • Alborzi P.
        • Satyan S.
        • Light R.P.
        Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.
        Hypertension. 2009; 53: 500-507
        • Hecking M.
        • Karaboyas A.
        • Antlanger M.
        • et al.
        Significance of interdialytic weight gain versus chronic volume overload: consensus opinion.
        Am J Nephrol. 2013; 38: 78-90
        • Frank Peacock W.
        • Soto K.M.
        Current technique of fluid status assessment.
        Congest Heart Fail. 2010; 16: S45-S51
        • Wizemann V.
        • Schilling M.
        Dilemma of assessing volume state–the use and the limitations of a clinical score.
        Nephrol Dial Transplant. 1995; 10: 2114-2117
        • Agarwal R.
        • Andersen M.J.
        • Pratt J.H.
        On the importance of pedal edema in hemodialysis patients.
        Clin J Am Soc Nephrol. 2008; 3: 153-158
        • Siriopol D.
        • Hogas S.
        • Voroneanu L.
        • et al.
        Predicting mortality in haemodialysis patients: a comparison between lung ultrasonography, bioimpedance data and echocardiography parameters.
        Nephrol Dial Transplant. 2013; 28: 2851-2859
        • Moissl U.
        • Arias-Guillen M.
        • Wabel P.
        • et al.
        Bioimpedance-guided fluid management in hemodialysis patients.
        Clin J Am Soc Nephrol. 2013; 8: 1575-1582
        • Onofriescu M.
        • Hogas S.
        • Voroneanu L.
        • et al.
        Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial.
        Am J Kidney Dis. 2014; 64: 111-118
        • Weir M.R.
        Relative plasma volume monitoring and blood pressure control: an overlooked opportunity to achieve dry weight in the hemodialysis patient.
        Hypertension. 2010; 55: 226-227
        • Sinha A.D.
        • Light R.P.
        • Agarwal R.
        Relative plasma volume monitoring during hemodialysis aids the assessment of dry weight.
        Hypertension. 2010; 55: 305-311
        • Agarwal R.
        • Bouldin J.M.
        • Light R.P.
        • Garg A.
        Inferior vena cava diameter and left atrial diameter measure volume but not dry weight.
        Clin J Am Soc Nephrol. 2011; 6: 1066-1072
        • Zager P.G.
        • Nikolic J.
        • Brown R.H.
        • et al.
        “U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc.
        Kidney Int. 1998; 54: 561-569
        • Zoccali C.
        Arterial pressure components and cardiovascular risk in end-stage renal disease.
        Nephrol Dial Transplant. 2003; 18: 249-252
        • Agarwal R.
        • Flynn J.
        • Pogue V.
        • Rahman M.
        • Reisin E.
        • Weir M.R.
        Assessment and management of hypertension in patients on dialysis.
        J Am Soc Nephrol. 2014; 25: 1630-1646
        • Charra B.
        • Chazot C.
        Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment.
        Nephron Physiol. 2003; 93: 94-101
        • Vertes V.
        • Cangiano J.L.
        • Berman L.B.
        • Gould A.
        Hypertension in end-stage renal disease.
        N Engl J Med. 1969; 280: 978-981
        • Davenport A.
        • Cox C.
        • Thuraisingham R.
        Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension.
        Kidney Int. 2008; 73: 759-764
        • Agarwal R.
        Hypervolemia is associated with increased mortality among hemodialysis patients.
        Hypertension. 2010; 56: 512-517
        • Wizemann V.
        • Wabel P.
        • Chamney P.
        • et al.
        The mortality risk of overhydration in haemodialysis patients.
        Nephrol Dial Transplant. 2009; 24: 1574-1579
        • Fagugli R.M.
        • Pasini P.
        • Quintaliani G.
        • et al.
        Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients.
        Nephrol Dial Transplant. 2003; 18: 2332-2338
        • Arneson T.J.
        • Liu J.
        • Qiu Y.
        • Gilbertson D.T.
        • Foley R.N.
        • Collins A.J.
        Hospital treatment for fluid overload in the Medicare hemodialysis population.
        Clin J Am Soc Nephrol. 2010; 5: 1054-1063
        • Zoccali C.
        • Torino C.
        • Tripepi R.
        • et al.
        Pulmonary congestion predicts cardiac events and mortality in ESRD.
        J Am Soc Nephrol. 2013; 24: 639-646
        • Elsayed M.E.
        • Stack A.G.
        What are the consequences of volume expansion in chronic dialysis patients? Pulmonary manifestations of volume expansion.
        Semin Dial. 2015; 28: 235-239
        • Charra B.
        • Laurent G.
        • Chazot C.
        • et al.
        Clinical assessment of dry weight.
        Nephrol Dial Transplant. 1996; 11: 16-19
        • Shoji T.
        • Tsubakihara Y.
        • Fujii M.
        • Imai E.
        Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients.
        Kidney Int. 2004; 66: 1212-1220
        • Henderson G.
        • Fahey T.
        • McGuire W.
        Nutrient-enriched formula versus standard term formula for preterm infants following hospital discharge.
        Cochrane Database Syst Rev. 2007; 4: CD004696
        • Zhu F.
        • Kuhlmann M.K.
        • Kotanko P.
        • Seibert E.
        • Leonard E.F.
        • Levin N.W.
        A method for the estimation of hydration state during hemodialysis using a calf bioimpedance technique.
        Physiol Meas. 2008; 29: S503-S516
        • Kuhlmann M.K.
        • Zhu F.
        • Seibert E.
        • Levin N.W.
        Bioimpedance, dry weight and blood pressure control: new methods and consequences.
        Curr Opin Nephrol Hypertens. 2005; 14: 543-549
        • Brennan J.M.
        • Ronan A.
        • Goonewardena S.
        • et al.
        Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic.
        Clin J Am Soc Nephrol. 2006; 1: 749-753
        • Chang S.T.
        • Chen C.L.
        • Chen C.C.
        • Lin F.C.
        • Wu D.
        Enhancement of quality of life with adjustment of dry weight by echocardiographic measurement of inferior vena cava diameter in patients undergoing chronic hemodialysis.
        Nephron Clin Pract. 2004; 97: c90-c97
        • Roueff S.
        • Martin E.
        • Chauffert M.L.
        • et al.
        Brain natriuretic peptide variations are linked to volume status in hemodialysis patients.
        Clin Nephrol. 2008; 70: 508-513
        • Levin N.W.
        • Kotanko P.
        • Eckardt K.U.
        • et al.
        Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes Controversies Conference.
        Kidney Int. 2010; 77: 273-284
        • Javed F.
        • Savkin A.V.
        • Chan G.S.
        • Mackie J.D.
        • Lovell N.H.
        Recent advances in the monitoring and control of haemodynamic variables during haemodialysis: a review.
        Physiol Meas. 2012; 33: R1-R31